LIVN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
LivaNova PLC is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is in a short-term uptrend and the pre-market price is holding above key moving averages, but the evidence is mixed: there is no AI Stock Picker signal today, no recent news catalyst, neutral insider/hedge-fund activity, and the latest SwingMax entry was already triggered earlier with the stock up about 10% since then. My direct view is to hold off on buying aggressively at this level and wait for either a clearer pullback or fresh fundamental confirmation.
Technically, LIVN looks constructive but not compelling enough for an immediate buy. MACD histogram is positive at 0.242, though it is contracting, which suggests momentum is still positive but fading. RSI_6 at 54.3 is neutral, showing neither overbought nor oversold conditions. The moving averages are bullish with SMA_5 > SMA_20 > SMA_200, which supports an established uptrend. Price is near the pivot at 72.81 and only slightly above it, with resistance at 75.19 and 76.66 and support at 70.43 and 68.96. In short: trend is positive, but the current entry is not especially attractive for an impatient buyer.
["Bullish technical structure with SMA_5 > SMA_20 > SMA_200", "MACD remains positive", "Mizuho raised price target to $90 and kept Outperform", "Baird said Q1 beat-and-raise results reflected broad portfolio strength and tailwinds emerging", "SwingMax previously issued an entry signal and the stock has already gained about 10.14% since then"]
["No news in the recent week", "AI Stock Picker shows no signal today", "SwingMax entry was already triggered earlier, so this is no longer an early entry setup", "Analyst actions are mixed, with Baird lowering its target to $76 and Barclays only Equal Weight", "Insiders and hedge funds are both neutral with no significant accumulation trend", "Pattern-based trend estimate suggests negative forward returns over the next week and month"]
No latest-quarter financial snapshot was available because the provided financial data returned an error, so I cannot assess the most recent quarter's revenue or earnings growth directly. Based on the analyst commentary, the company did deliver a beat-and-raise Q1, which is a positive sign for recent operating momentum and suggests the latest quarter season was strong enough to support higher targets from at least one major broker.
The analyst trend is mixed but still slightly positive. Mizuho raised its target to $90 and kept Outperform, which is the most bullish call in the set. Baird lowered its target to $76 from $78 but maintained Outperform, implying they still like the stock despite trimming expectations. Barclays raised its target slightly to $76 but kept only an Equal Weight rating. Wall Street pros therefore show a split: bulls see improving tailwinds and room to rerate, while the neutral camp suggests upside is more limited at the current price.
